TrialResearch and practice in thrombosis and haemostasis2026

Denecimig (Mim8) prophylaxis over 52 weeks in adolescents and adults with hemophilia A: FRONTIER2 extension study.

Victor Jiménez-Yuste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.